Mereo Biopharma Group Plc's total assets for Q2 2025 were $62.63M, a decrease of -8.33% from the previous quarter. MREO total liabilities were $8.45M for the fiscal quarter, a 2.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.